Texas NORML and other advocates had sought to further amend the bill to include eligibility for chronic pain patients and to raise the THC to five percent. House lawmakers agreed to the additional changes, but members of the Senate ultimately removed those provisions.
This updated edition reviews over 450 peer-reviewed studies assessing the safety and efficacy of either whole-plant cannabis or cannabinoids for 23 different patient populations.
“This study provides evidence that the types of cannabis available in recreational and medical cannabis dispensaries might hold promise as an alternative treatment for PTSD. … This study’s primary outcome supports the theory that cannabis should be [tested in clinical trials] as a potential therapeutic for PTSD.”
Members of the US House Committee on Veteran’s Affairs are demanding the Department of Veterans Affairs facilitate protocols to assess the efficacy of medical cannabis in veterans suffering from chronic pain and post-traumatic stress.
Michigan physicians may now authorize cannabis for the treatment of post traumatic stress. Post-traumatic stress syndrome is an anxiety disorder that is estimated to impact some eight million Americans annually. To date, there are no pharmaceutical treatments specifically designed or approved to target symptoms of PTSD.
Patients diagnosed with post-traumatic stress, Crohn’s disease, and other debilitating disorders will now be eligible for cannabis therapy, under legislation approved yesterday absent the Governor’s signature. The new law expands the list of qualifying conditions for which a Maine physician may legally recommend cannabis to include “post-traumatic stress disorder,” “inflammatory bowel disease” (such as Crohn’s and/or ulcerative colitis), and “dyskinetic and spastic movement disorders and other diseases causing severe and persistent muscle spasms” (such as Parkinson’s disease and/or Huntington’s disease).
House and Senate lawmakers last week gave final approval to legislation, LD 1062, to allow patients diagnosed with post-traumatic stress, inflammatory bowel disease, and other debilitating disorders to be eligible to engage in the therapeutic use of cannabis.